Sysmex Corporation

Sysmex and Optim agreed to establish a joint venture in January for developing digital medicine services and platforms, combining Sysmex's sales network with Optim's AI technologies.

Sysmex America, Inc. held a dedication ceremony for its expanded reagent manufacturing facility in Mundelein, Illinois. The $24 million investment nearly doubles square footage and increases production capacity by nearly 80 percent.